Your browser doesn't support javascript.
loading
Validation of the imatinib-therapy failure model.
Zhang, Xiaoshuai; Gale, Robert Peter; Liu, Bingcheng; Huang, Jian; Zhang, Yanli; Du, Xin; Weng, Jianyu; Li, Weiming; Xu, Na; Liu, Xiaoli; Chen, Chunyan; Lin, Hai; Li, Guohui; Liang, Rong; Liu, Zhuogang; Wang, Xiaodong; Zhang, Yanqing; Han, Yanqiu; Liu, Chunshui; Hu, Jianda; Lin, Lie; Yang, Wei; Liu, Zhenfang; Meng, Li; Tu, Chuanqing; Zheng, Caifeng; Zhou, Zeping; Bai, Yanliang; Qiu, Huiying; Chen, Suning; Li, Fei; Guo, Jianxin; Liu, Zelin; Sun, Hui; Zhou, Li; Feng, Ru; Sun, Xiuli; Huang, Xiaojun; Jiang, Qian.
Afiliação
  • Zhang X; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Gale RP; Centre for Hematology Research, Department of Immunology and Inflammation, Imperial College London, London, UK.
  • Liu B; National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
  • Huang J; Department of Hematology, he First Affiliated Hospital of Zhejiang University, College of Medicine, Zhejiang University, Department of Hematology, The Fourth Affiliated Hospital of Zhejiang University, College of Medicine, Zhejiang University, Zhejiang Provincial Clinical Research Center for Haemato
  • Zhang Y; Henan Cancer Hospital, The Affiliate Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Du X; Division of Hematology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Guangdong, China.
  • Weng J; Department of Hematology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Li W; Union hospital, Tongji Medical college, Huazhong University of Science and Technology, Wuhan, China.
  • Xu N; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Liu X; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Chen C; Department of Hematology, Qilu Hospital of Shandong University, Jinan, China.
  • Lin H; Department of hematology, First Hospital of Jilin University, Jilin, China.
  • Li G; Xi'an international medical center hospital, Shanxi, China.
  • Liang R; Department of Hematology, Xijing Hospital, Airforce Military Medical University, Shanxi, China.
  • Liu Z; Shengjing Hospital of China Medical University, Shenyang, China.
  • Wang X; Sichuan Academy of Medical Sciences Sichuan Provincial People's Hospital, Chengdu, Sichuan, China.
  • Zhang Y; Department of Hematology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
  • Han Y; The affiliated hospital of Inner Mongolia Medical University, Inner Mongolia, China.
  • Liu C; Department of Hematology, Cancer Center, The First Hospital of Jilin University, Changchun, China.
  • Hu J; Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Medical University Union Hospital, Fujian, China.
  • Lin L; Department of Hematology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.
  • Yang W; Shengjing Hospital of China Medical University, Shenyang, China.
  • Liu Z; Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
  • Meng L; Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Tu C; Department of Hematology, Shenzhen Baoan Hospital, Shenzhen University Second Affiliated Hospital, Shenzhen, China.
  • Zheng C; Department of Hematology, Shenzhen Baoan Hospital, Shenzhen University Second Affiliated Hospital, Shenzhen, China.
  • Zhou Z; Department of Hematology, the Second Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, China.
  • Bai Y; Department of Hematology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, China.
  • Qiu H; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, China.
  • Chen S; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, China.
  • Li F; Center of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Guo J; Department of Hematology, The Second Affiliated Hospital of Fujian Medical University, Fujian, China.
  • Liu Z; Department of Hematology, Huazhong University of Science and Technology Union Shenzhen Hospital (Nanshan Hospital), Shenzhen, China.
  • Sun H; Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Zhou L; Department of Leukemia, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Feng R; Department of Hematology, Beijing Hospital, National Center of Gerontology, Beijing, China.
  • Sun X; Department of hematology, The first affiliated hospital of Dalian Medical University, Dalian, China.
  • Huang X; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China. huangxiaojun@bjmu.edu.cn.
  • Jiang Q; Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China. huangxiaojun@bjmu.edu.cn.
Leukemia ; 37(5): 1166-1169, 2023 05.
Article em En | MEDLINE | ID: mdl-36973351
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antineoplásicos Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antineoplásicos Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido